Principal Financial Group Inc Neuro Pace Inc Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Neuro Pace Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 18,065 shares of NPCE stock, worth $179,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,065Holding current value
$179,566% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
105Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$26 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$25.7 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$23 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$13.7 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$13.6 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $247M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...